Table of Contents Author Guidelines Submit a Manuscript

Kidney Stone Disease: State of the Art and Future Directions in Imaging, Treatment, and Prevention

Call for Papers

The lifetime risk of developing kidney stones is approximately 1 in 11 adults among adults in the United States. Approximately 50% of first-time stone formers develop a recurrence within 5 years. Recent evidence also suggests that the incidence and prevalence of kidney stones in the pediatric population are rising and that stone recurrence rates in children parallel those in adults. Estimated associated healthcare costs are high, totaling $5 billion in 2000.

There is worldwide variation in the current management and prevention of kidney stones, due in part to gaps in the evidence supporting various aspects of clinical management and/or evidence of efficacy of rapidly emerging new technologies or surgical techniques. There have been several recent developments in the areas of the medical and surgical management of kidney stones, including the development of novel imaging modalities, emergence of new surgical techniques, and description of novel dietary prevention strategies among others. Interest in the impact of stone disease on patient quality of life has also gained traction.

We invite investigators to contribute original research articles as well as reviews on the current state of the art and future directions in the clinical management of kidney stone disease in adults and children, with specific focus on imaging, innovation in surgical techniques and new technologies, disease prevention, and quality of life.

Potential topics include but are not limited to the following:

  • Current and emerging imaging modalities for kidney stone disease: selection, accuracy, advantages and disadvantages, and costs
  • Innovations in shockwave lithotripsy and impact on outcomes
  • HoYAG lithotripsy for kidney stones : what do we know in 2018?
  • Percutaneous nephrolithotomy: does size matter?
  • Current role of open, laparoscopic, or robotic surgery in the management of kidney stone disease
  • Future technologies for kidney stone treatment
  • Genetics of kidney stone disease: what do we know?
  • Emerging evidence for dietary prevention of stone disease
  • Metabolic abnormalities in kidney stone patients: current state of the art and emerging approaches in diagnosis, prevention, and treatment
  • Development and validation of quality of life assessment tools for kidney stone patients

Authors can submit their manuscripts through the Manuscript Tracking System at

Submission DeadlineFriday, 3 August 2018
Publication DateDecember 2018

Papers are published upon acceptance, regardless of the Special Issue publication date.

Lead Guest Editor

  • Ephrem Olweny, Rutgers-Robert Wood Johnson Medical School, New Brunswick, USA

Guest Editors